Myth-buster

Thistle extract at 280 mg/day failed to lower creatinine in a meta-analysis — the null result was raked over 200 studies.

This is one of the first systematic analyses of thistle for kidney function, and its null finding directly challenges popular claims — but the picture is now contested, not settled, because the same review found a benefit in a specific clinical scenario (drug-induced acute kidney injury) that doesn't apply to most supplement users.

A meta-analysis of several clinical trials found that taking 280 mg of silymarin (the active compound in milk thistle) daily did not significantly reduce serum creatinine, a blood marker of kidney strain. However, the review did find that silymarin lowered creatinine in people with acute kidney injury caused by medications — meaning the supplement's effect depends heavily on the specific condition, and the null result here applies to chronic kidney disease and to the 280 mg dose tested.

Where this fits in the evidence

This is among the first studies we've indexed on Thistle for Reduced Serum Creatinine Levels — treat it as an early signal until more research accumulates.

The study

Nephroprotective Effects of Silymarin: A Systematic Review and Meta-Analysis.

Meta-Analysis
2025-08-01
Biochemistry. Biokhimiia

More on Thistle More on Reduced Serum Creatinine Levels

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.